المؤلفون: Zhao SJ, Wang DH, Li YW, Han L, Xiao X, Ma M, Wan DC, Hong A, Ma Y

المصدر: International Journal of Nanomedicine, Vol Volume 12, Pp 2143-2160 (2017)

مصطلحات موضوعية: pituitary adenylate cyclase activating peptide (PACAP)-derived peptide, nano-selenium, VPAC2 receptor, synergy effect, type 2 diabetes (T2D), Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://www.dovepress.com/a-novel-selective-vpac2-agonist-peptide-conjugated-chitosan-modified-s-peer-reviewed-article-IJN; https://doaj.org/toc/1178-2013

URL الوصول: https://doaj.org/article/2c4da66d5a8f49aeb79eb0c9e773df2a